The largest database of trusted experimental protocols

Hs5 human bone marrow stromal cell line

Sourced in United States

The HS5 human bone marrow stromal cell line is a well-characterized, immortalized cell line derived from human bone marrow. It is commonly used as a model system for the study of various cellular processes, including cell-cell interactions, cytokine production, and hematopoietic support.

Automatically generated - may contain errors

2 protocols using hs5 human bone marrow stromal cell line

1

Isolation and culture of primary B cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HS5 human bone marrow stromal cell line was obtained from the American Type Culture Collection (ATTC) and cultured in DMEM medium (GIBCO) supplemented with 10% v/v FBS, 15 mg/mL Pen/Strep at 37°C and 5% CO2. Primary leukaemic, from patients, and healthy, from donors, CD19+ B cells were negatively selected from fresh PB and BM using the RosetteSep B lymphocyte enrichment kit (Stemcell Technologies) and separated via density gradient Lymphoprep (Stemcell Technologies). Healthy B cells were then isolated with EasySep Cell isolation kit (Stemcell Technologies). B cells were isolated from lymphoid tissues after mechanical smashing to recover the cells in suspension and later purified following the same protocol described for healthy B cells. The purity of all the isolated B cells was >98%. Primary cells were cultured in RPMI 1640 medium (EuroClone) supplemented with 10% (v/v) Fetal Bovine Serum (FBS) and 15 mg/mL Pen/Strep (complete RPMI) at 37°C and 5% CO2.
+ Open protocol
+ Expand
2

Isolation and Culture of CLL Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HS5 human bone marrow stromal cell line immortalized by E6/E7 (11 (link)), was obtained from American Type Culture Collection (Manassas, VA, USA). A total of 62 patients (male and female; aged 38–85 years) diagnosed with typical B-CLL were recruited from the First Affiliated Hospital of Nanchang University (Nanchang, China) in the present study. The diagnosis was based on clinical criteria and laboratory features, according to National Cancer Institute Criteria (19 (link)). All patients provided written informed consent, and the present study was approved by the ethics committee of The First Affiliated Hospital of Nanchang University. In all experiments, CLL cells were isolated from peripheral blood samples, which were collected from the patients, by density gradient centrifugation (20 (link)). Briefly, 5 ml blood was slowly added to a Falcon tube containing 6 ml pre-warmed Fico/Lite LymphoH buffer (Atlanta Biological, Lawrenceville, GA, USA) and then centrifuged at 435 × g for 20 min at room temperature. The isolated CLL cells was washed with pre-warmed PBS and incubated in RPMI-1640 medium (Cellgro; Mediatech, Inc., Hendon, VA, USA) supplemented with 10% fetal bovine serum, penicillin (100 U/ml) and streptomycin (100 µg/ml; all from Cellgro; Mediatech, Inc.) overnight prior to experimentation.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!